News
HEAL Technology: The next generation of antithrombogenic coating
NewsThe HEAL Technology mimics the final step of natural haemostasis and thus the conversion of fibrinogen (by thrombin) to fibrin.
Presentation of the BETYS study at the offices of Angionautix S.L.
NewsDr. Carlos Perez Garcia, neuroradiologist from Clínico San Carlos Hospital (Madrid) presented the BETYS registry at Angionautix Headquarters.
Recruited the first 53 patients in the AQUAS registry
NewsAQUAS Registry gets ethics committee full clearance to start.
Angionautix was present at RSNA 2022
NewsAngionautix present at the RSNA congress in Chicago to implement the best diagnostic assistance tools through Artificial Intelligence in our territories. Improving the daily life of our radiologists with the most innovative help.
The AQUAS registry is currently in the analysis phase of the results after the recruitment of 126 patients
NewsAQUAS Registry gets ethics committee full clearance to start.
First published clinical series on combined technique thrombectomy using the MIVI Neuroscience Q aspiration catheter. Dr. Sebastià Remollo (Badalona, Spain)
NewsFirst published clinical series on combined technique thrombectomy using the MIVI Neuroscience Q aspiration catheter. Dr. Sebastià Remollo (Badalona, Spain)
First Derivo 8×50 case implanted in Iberia
NewsSplenic giant aneurysm treated with one single device deployed through NeuroBridge 39 (Acandis)
Angionautix closes exclusive distribution agreement with MicroPort
NewsAngionautix closes exclusive distribution agreement with MicroPort, one of the world’s largest medical device manufacturer
The 0-TICI-0 registry is currently in the analysis phase of the results after the recruitment has been completed.
News0-TICI-0 Study for IC stenting as rescue technique for failed thrombectomy in the acute Stroke context
CUSTOMER SUPPORT
Edificio Torre Europa,
Paseo de la Castellana 95, planta 29
28046, Madrid